Shearman & Sterling represented GMS Ventures and Investments in the transaction. Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an...
Shearman & Sterling represented GMS Ventures and Investments in the transaction. Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an...